GC Cell Corp
KOSDAQ:144510
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GC Cell Corp
KOSDAQ:144510
|
KR |
|
Ryanair Holdings PLC
ISEQ:RYA
|
IE |
|
D
|
DigitalOcean Holdings Inc
DUS:0SU
|
US |
|
H
|
Humana Inc
DUS:HUM
|
US |
|
E
|
Enagas SA
DUS:EG4
|
ES |
|
J
|
Japan Tobacco Inc
XMUN:JAT
|
JP |
|
Telkom Indonesia (Persero) Tbk PT
F:PTI
|
ID |
|
T
|
Takeda Pharmaceutical Co Ltd
XMUN:TKD
|
JP |
|
Snipp Interactive Inc
XTSX:SPN
|
CA |
|
B
|
Broadcom Inc
SWB:1YD
|
US |
|
M
|
Medican Enterprises Inc
OTC:MDCN
|
US |
|
E
|
Equinor ASA
DUS:DNQ
|
NO |
|
S
|
Sofina SA
SWB:8FS
|
BE |
|
P
|
Parker-Hannifin Corp
XMUN:PAR
|
US |
|
T
|
TAL Education Group
SWB:IZZ
|
CN |
|
E
|
Engie SA
XMUN:GZF
|
FR |
|
Teleperformance SE
F:RCF0
|
FR |
|
Softronic AB
STO:SOF B
|
SE |
|
Agricultural Bank of China Ltd
OTC:ACGBF
|
CN |
|
I
|
Intuit Inc
BMV:INTU
|
US |
|
T
|
True North Energy Corp
OTC:TNEN
|
US |
|
MP Materials Corp
F:55H0
|
US |
|
L
|
Lundin Mining Corp
SWB:GXD
|
CA |
|
R
|
Rex Trueform Group Ltd
JSE:RTN
|
ZA |
Bankruptcy Probability
GC Cell Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
GC Cell Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
G
|
GC Cell Corp
KOSDAQ:144510
|
219.1B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
GC Cell Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, GC Cell Corp has total debt of 103.6B KRW. This includes both short-term (81.6B KRW) and long-term (22B KRW) debt.
You can find a full breakdown on its Balance Sheet.